Evidence map›Paper›PMID 33587397›Full record

Trial reportJournal of clinical psychopharmacology

Effects of Oxytocin on Emotion Recognition in Schizophrenia: A Randomized Double-Blind Pilot Study.

Elissar Andari, Nicholas M Massa, Molly D Fargotstein, Nicholas B Taylor, David M Halverson, Andrew V Owens, Danielle L Currin, Arpita Bhattacharya, Dmitriy Gitman, Bruce C Cuthbert and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of clinical psychopharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Elissar AndariFrom the Department of Psychiatry, College of Medicine and Life Sciences, University of Toledo, Toledo, OH.
Nicholas M Massa
Molly D FargotsteinAtlanta Veterans Affairs Health Care System, Decatur.
Nicholas B TaylorAtlanta Veterans Affairs Health Care System, Decatur.
David M HalversonDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA.
Andrew V OwensDepartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA.
Danielle L Currin
Arpita Bhattacharya
Dmitriy GitmanAtlanta Veterans Affairs Health Care System, Decatur.
Bruce C Cuthbert
Larry J Young
Erica J Duncan
Atlanta VA Health Care System · USEmory University · USUniversity of California, Los Angeles · USUniversity of Toledo · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
The Impact of Oxytocin on the Neural Representation Social Stimuli P50MH100023 · NIMH · EMORY UNIVERSITY · PI SANCHEZ, MAR M · 2013 to 2022
$21.8M
NIH HHS P51 OD011132NIMH NIH HHS P50 MH100023
6 · The paper itself

Abstract

backgroundSchizophrenia (SCZ) is a neurodevelopmental disorder that leads to poor social function. Oxytocin (OXT), a neuropeptide involved in social cognition, is a potential therapeutic agent for alleviating social dysfunction. Therefore, we investigated the effects of intranasal oxytocin (IN-OXT) on emotional processes in experimental interactive social contexts in individuals with SCZ.

methodsIn a male-only parallel randomized placebo-controlled double-blind trial, we investigated the effects of IN-OXT (24 IU) on visual fixation on pictures of faces and emotion recognition in an interactive ball-tossing game that probed processing of social and nonsocial stimuli.

resultsIntranasal oxytocin enhanced the recognition of emotions during an emotion-based ball-tossing game. This improvement was specific to the game that included social cue processing. Intranasal oxytocin did not affect eye gaze duration or gaze dwell time on faces in these patients.

conclusionsAn acute low dose of IN-OXT had a modest effect on social cue processing and was limited to emotion recognition. Higher doses and long-term trials targeting emotional processing in SCZ may lead to improved social function.

Indexed as

EmotionsAdministration, IntranasalAdultCase-Control StudiesDose-Response Relationship, DrugDouble-Blind MethodFixation, OcularHumansMaleMiddle AgedOxytocinPilot ProjectsRecognition, PsychologySchizophreniaSocial PerceptionOxytocin

Identifiers

PMID33587397
PMCPMC8186294
OpenAlexW3130519456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.